Heron Therapeutics Inc (HRTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Heron Therapeutics Inc (HRTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7096
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-based drug delivery platform, which improves the therapeutic profile of injectable pharmaceuticals. The company’s first commercial product,Sustol is an extended-release injection indicated in combination with other antiemetics in adults for the prevention of nausea and vomiting due tomoderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. Heron’s developmental pipeline includes HTX-011 for post-operative pain management and Cinvanti (HTX-019) for chemotherapy-induced nausea and vomiting (CINV) prevention. Heron is headquartered in San Diego, California, the US.

Heron Therapeutics Inc (HRTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Heron Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Heron Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Heron Therapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Heron Therapeutics Raises USD200 Million in Public Offering of Shares 10
Heron Therapeutics Prices Public Offering of Shares for USD156 Million 12
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 14
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 16
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 18
Heron Therapeutics Inc – Key Competitors 19
Heron Therapeutics Inc – Key Employees 20
Heron Therapeutics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 08, 2018: Heron Therapeutics announces financial results for the three and six months ended june 30, 2018 and recent corporate progress 22
May 10, 2018: Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress 24
Feb 27, 2018: Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress 26
Aug 09, 2017: Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 28
May 10, 2017: Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 29
Feb 23, 2017: Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress 30
Corporate Communications 31
Apr 24, 2017: Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, Finance 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Heron Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Heron Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Heron Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Heron Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Heron Therapeutics Raises USD200 Million in Public Offering of Shares 10
Heron Therapeutics Prices Public Offering of Shares for USD156 Million 12
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 14
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 16
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 18
Heron Therapeutics Inc, Key Competitors 19
Heron Therapeutics Inc, Key Employees 20
Heron Therapeutics Inc, Other Locations 21

List of Figures
Heron Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Heron Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Heron Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Heron Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Heron Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Heron Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Heron Therapeutics Inc (HRTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Bristow Group Inc:企業の戦略・SWOT・財務分析
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • British Arab Commercial Bank plc:企業の戦略的SWOT分析
    British Arab Commercial Bank plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • AMETEK Inc (AME):電力:M&Aディール及び事業提携情報
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Unicaja Banco SA:企業の戦略・SWOT・財務分析
    Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report Summary Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Greif, Inc.:企業の戦略・SWOT・財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Neuland Laboratories Ltd (NEULANDLAB):企業の財務・戦略的SWOT分析
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • EKF Diagnostics Holdings Plc (EKF):企業の財務・戦略的SWOT分析
    EKF Diagnostics Holdings Plc (EKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • The Depository Trust & Clearing Corp:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Rogers Communications, Inc.:企業の戦略・SWOT・財務情報
    Rogers Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rogers Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務情報
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EnSync Inc (ESNC):電力:M&Aディール及び事業提携情報
    Summary Ensync Inc (Ensync), formerly ZBB Energy Corp, is a technology solutions company that develops and markets energy management systems. The company provides products such as energy management, internet of energy, energy storage, system support, system design and resources, among others. Its en …
  • The Ultimate Software Group, Inc. (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group, Inc. (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Occidental Petroleum Corporation:企業の戦略・SWOT・財務分析
    Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Occidental Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • New Age Metals Inc:企業の戦略・SWOT・財務情報
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ayala Corporation (AC)-エネルギー分野:企業M&A・提携分析
    Summary Ayala Corporation (Ayala) is a business conglomerate with diversified business groups. It operates in real estate, financial services, water, telecommunications, automotive, power generation, transport infrastructure, electronics manufacturing services, business process outsourcing, educatio …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆